Search results
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 20 hours agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks via Yahoo Finance· 6 days agoStocks recently featured in the blog include: American Express Co. AXP, Walmart Inc. WMT, Amazon.com...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck & Co...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 5 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 2 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 3 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 5 days agoAnd in 2023, Merck & Co’s venture arm participated in the company’s Series A extension, which raised...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 5 days agoBeyond 2030, the drugmaker expects to add radiopharmaceuticals, or hybrid radiation-emitting drugs,...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 5 days agoThe Phase 2a study AltruBio currently has underway in ulcerative colitis should produce results in...
Two local RNA-focused biotechs merge, plan to go public 'at some point' - Boston Business Journal
The Business Journals· 2 days agoWatertown’s Orna Therapeutics, a circular RNA startup, said Thursday that it will acquire...